Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial)

Claudia Marchetti; Riccardo Tudisco; Vanda Salutari; Antonella Pietragalla; Giovanni Scambia; Anna Fagotti

doi:10.1136/ijgc-2021-002727

Article info

Clinical trial

Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial)

Authors

Claudia Marchetti Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articles Google scholar articles
Riccardo Tudisco Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articles Google scholar articles
Vanda Salutari Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articles Google scholar articles
Antonella Pietragalla Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articles Google scholar articles
Giovanni Scambia Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articles Google scholar articles
Anna Fagotti Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy PubMed articles Google scholar articles

Correspondence to Anna Fagotti, Woman and Child's Health Department, Universita Cattolica del Sacro Cuore Facolta di Medicina e Chirurgia, Roma, 00168 Roma RM, Italy; annafagotti70{at}gmail.com

View Full Text

Citation

Marchetti C, Tudisco R, Salutari V, et al

Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial)

International Journal of Gynecologic Cancer 2021;31:1175-1178.

Publication history

Accepted May 27, 2021
First published June 15, 2021.

Online issue publication

August 02, 2021

Article Versions

Previous version (15 June 2021).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password